Robert W. Baird Upgrades Express Scripts (ESRX) to Outperform
Robert W. Baird upgraded shares of Express Scripts (NASDAQ:ESRX) from a neutral rating to an outperform rating in a research note published on Friday morning, MarketBeat reports. The firm currently has $81.00 price objective on the stock, up from their prior price objective of $72.00.
Several other equities research analysts also recently weighed in on ESRX. SunTrust Banks set a $82.00 price target on Express Scripts and gave the stock a buy rating in a report on Thursday, December 14th. BidaskClub upgraded Express Scripts from a hold rating to a buy rating in a report on Thursday, December 14th. Maxim Group increased their price target on Express Scripts from $78.00 to $87.00 and gave the stock a buy rating in a report on Thursday, December 14th. Sanford C. Bernstein upgraded Express Scripts from an underperform rating to a market perform rating in a report on Wednesday, December 6th. Finally, ValuEngine upgraded Express Scripts from a hold rating to a buy rating in a report on Monday, October 2nd. Five analysts have rated the stock with a sell rating, ten have given a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. The company has a consensus rating of Hold and an average target price of $74.40.
Shares of Express Scripts (NASDAQ ESRX) opened at $73.38 on Friday. Express Scripts has a 52-week low of $55.80 and a 52-week high of $73.46. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.61 and a current ratio of 0.73. The stock has a market capitalization of $40,523.99, a P/E ratio of 10.46, a price-to-earnings-growth ratio of 1.06 and a beta of 0.88.
In other news, CEO Timothy C. Wentworth acquired 8,000 shares of the company’s stock in a transaction that occurred on Tuesday, October 31st. The shares were bought at an average price of $61.13 per share, with a total value of $489,040.00. Following the completion of the purchase, the chief executive officer now directly owns 98,628 shares in the company, valued at $6,029,129.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Phyllis S. Anderson sold 643 shares of the stock in a transaction that occurred on Wednesday, November 1st. The stock was sold at an average price of $62.37, for a total value of $40,103.91. The disclosure for this sale can be found here. 0.68% of the stock is owned by corporate insiders.
Large investors have recently made changes to their positions in the stock. Trust Co boosted its position in Express Scripts by 5.9% during the 1st quarter. Trust Co now owns 3,572 shares of the company’s stock valued at $235,000 after acquiring an additional 200 shares in the last quarter. Capital Asset Advisory Services LLC bought a new stake in Express Scripts during the 2nd quarter valued at $312,000. Factory Mutual Insurance Co. boosted its position in Express Scripts by 2.4% during the 2nd quarter. Factory Mutual Insurance Co. now owns 766,488 shares of the company’s stock valued at $48,933,000 after acquiring an additional 18,000 shares in the last quarter. Atria Investments LLC boosted its position in Express Scripts by 53.1% during the 2nd quarter. Atria Investments LLC now owns 9,431 shares of the company’s stock valued at $602,000 after acquiring an additional 3,270 shares in the last quarter. Finally, Private Trust Co. NA boosted its position in Express Scripts by 13.8% during the 2nd quarter. Private Trust Co. NA now owns 11,351 shares of the company’s stock valued at $724,000 after acquiring an additional 1,378 shares in the last quarter. 88.44% of the stock is currently owned by institutional investors.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.